QR-koodi

Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.

Treatment with the combination of aspirin and dipyridamole is believed to reduce the incidence of coronary vein graft occlusion. A double blind randomised controlled trial was carried out in which aspirin 990 mg and dipyridamole 225 mg daily or placebo were added to the routine postoperative managem...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br Heart J
Päätekijät: Brooks, N, Wright, J, Sturridge, M, Pepper, J, Magee, P, Walesby, R, Layton, C, Honey, M, Balcon, R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 1985
Aiheet:
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481740/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3881108/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.2.201
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!